KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia releases final data from P2 paxalisib trial, page-103

  1. 1,074 Posts.
    lightbulb Created with Sketch. 452
    You've lost me now apologies.

    IMHO, good biotechs on asx are very slim pickings. Simcare may have done DD, but I would like to also.

    My questions remain, anyone else have an answer?

    Let's hope for GBM patients pax offers survival benefit.

    GLTA.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.